Holland & Knight Welcomes MARC Associates - Experts in Health Care and Intergovernmental Policy - to the Firm's Public Policy & Regulatio...(h Care Bringing a blend of seas...),Health
Navigation Links
Holland & Knight Welcomes MARC Associates - Experts in Health Care and Intergovernmental Policy - to the Firm's Public Policy & Regulation Practice
Date:12/11/2008
h Care
Bringing a blend of seasoned public health advocacy and regulatory know-how, the MARC health care team complements and broadens our health care practice group's policy experience. The team is well respected before the U.S. Congress and the Department of Health and Human Services, including the Centers for Medicare and Medicaid Services, Agency for Healthcare Research and Quality, and the National Institutes of Health. The team includes a former CMS official, a former Medicare Carrier Director, and a coding expert and delivers a new technical and strategic regulatory/reimbursement capability for the firm. These additions will benefit our health care practice and enable our firmwide interdisciplinary Health Law & Life Sciences Team to offer deeper regulatory capabilities to existing health care clients.
Randolph Fenninger joins as a Senior Policy Advisor. Fenninger has more than 30 years experience representing healthcare clients before Congress, the Executive Branch, independent regulatory agencies and public and private health plans. After nine years in government relations with the American Medical Association, he joined MARC Associates as a partner in 1985.
Ellen Riker joins as a Senior Policy Advisor. Riker has 25 years of legislative, regulatory, and operational expertise in Medicare, and other federal medical research and health policies. She served six years on the Professional Staff of the House Energy and Commerce Committee, working on public health and Medicare issues and several years in hospital administration.
Other health team members are Sheila Madhani, Laurence Clark, MD, Bernard Patashnik and Johanna Gray.
Intergovernmental Relations
The MARC intergovernmental team led by Dan Maldonado and Eve Maldonado
O'Toole has special expertise in advocating for local governments. They bring
to Holland & Knight a list of distinguished clients that
'/>"/>
| SOURCE Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Hollander Consultants Celebrates 25 Years as an Industry Leader in Successful Medical Practice Management Consulting
2. Holland America Line Program Surpasses $1 Million Raised for Susan G. Komen for the Cure(R)
3. Deep Sedation Becoming More Common for Dying Patients in Holland
4. Congressman Hoekstra Tours Holland Pathology Laboratory; Learns Vital Role In Patient Care
5. UF McKnight Brain Institute director honored by Italian scientists
6. Perr&Knight Announces Discounted Fee Schedule for Access to Its Online Database of Commercial Lines Competitor Filings
7. Jane M. Knight Recognized By Strathmores Whos Who Worldwide Publication
8. Southern Research Institute Names Blaine Knight Vice President of Drug Discovery
9. Knights Distribute $1 Million Worth of Wheelchairs to Veterans
10. Knights to Distribute $1 Million Worth of Wheelchairs for Veterans
11. Knights of Columbus to Distribute Wheelchairs to Veterans in Need
Post Your Comments:
(Date:12/4/2009)...ire/ -- Pamela Bowen, Chief Information Officer at...or the "Chief Innovation Officer" Appy Award for t...cloud computing. Appy Award recipients are nominat...RM or the Force.com platform in bringing new level...artner, service, support or IT organizations. ,...
(Date:12/4/2009)... cancers, particularly Ewing sarcomas and tumors o...tudy published online December 4 in the Journal o...as undertaken because there is limited research on...) for pediatric cancer patients. , Karen Wasilew...lood Disorders Service, Children,s Healthcare of A...
(Date:12/4/2009)... from the School of Medicine,s Department of Nutri...ch products of lipid peroxidation and some drugs o... The pathways were identified by a combination of ...dings shed new light on the mechanism of action of...wn as "the date rape drug." The manuscript publish...
(Date:12/4/2009)...phenomenon that was started by people that were lo...al work in the US, Canada, and other countries. In... have found that Mexican Dental Vacation is a grea... (PRWEB) December 4, 2009 -- Aft...n Dental Vacation is seeing their best year ever, ...
(Date:12/4/2009)...ators to crack down on abuse of opioid medications...The makers of 24 different prescription painkiller...s to curb the abuse of these opioid drugs. , T...re from U.S. Food and Drug Administration official...doses that occur with these medications each year,...
Breaking Medicine News(10 mins):Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Makers of Powerful Painkillers Present Safety Plans 2[0] Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist[0] News brief -- childhood cancer survivor study report: Late recurrence is a risk for some cancers[0] Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week'[0] Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor [0] Makers of Powerful Painkillers Present Safety Plans
..., yet 2 million people die of cardiovascular disea...e is now affecting younger generations due to unhe...ture deaths. Recent studies have highlighted the ... to develop national strategies to combat heart di...
...M) has,focused its culinary expertise this time to...u salivating for more. Italians have known for cen...age as natural as spaghetti and,meatballs. Now Twi...ew., (Photo: http://www.newscom.com/cgi-bin/prnh...
...lutions, Inc.,(Accuro) (http://www.accurohealth.c...cle management market with the acquisition of TPMS...rovides contract management services to a,strong c...MS,personnel to continue to provide the excellent ...
... Hyperion,Therapeutics, Inc., a privately held bio...S. Zoth has been elected to the company,s Board of...e President and Chief,Financial Officer of MedImmu...n discussing her appointment, Ms. Zoth commented, ...
...ncrease the bronchoscopy market, to approximately...earch Group, WALT...,Research Group,s US Markets for ENT & Bronchoscop... to $180 million by 2012., To date, the majority ...
...ific Corporation (NYSE: BSX ) today announced the...ounsel. Pratt is a nationally known,attorney speci...ation. He,will hold the title of "Executive Vice P...cer Jim Tobin. He plans to join,the Company May 1s...
Other Medicine News:Health News:Joining efforts to tackle heart disease 2Health News:Joining efforts to tackle heart disease 3Health News:New Twin Hens Beef Pot Pies with Organic Cornmeal Now Provide The Brand's Famous Artisan Comfort Food for Gluten-free Connoisseurs 2Health News:Hyperion Therapeutics Elects Lota Zoth to Board of Directors 2Health News:Interventional Pulmonology Creeping into Bronchoscopy Market 2Health News:Boston Scientific Announces Appointment of Timothy Pratt as General Counsel 2Health News:Boston Scientific Announces Appointment of Timothy Pratt as General Counsel 3Joining efforts to tackle heart diseaseNew Twin Hens Beef Pot Pies with Organic Cornmeal Now Provide The Brand's Famous Artisan Comfort Food for Gluten-free ConnoisseursAccuro Healthcare Solutions Acquires TPMSHyperion Therapeutics Elects Lota Zoth to Board of DirectorsInterventional Pulmonology Creeping into Bronchoscopy MarketBoston Scientific Announces Appointment of Timothy Pratt as General Counsel
(Date:12/4/2009)..., , BILLERICA, Mass., Dec. 4 /PRNewswi...y-owned subsidiary of Volcano Corporation (Nasdaq:...and successful testing of a novel integrated light...ves this proprietary optical engine design raises ... limitations of laser-based designs for swept sour...
(Date:12/4/2009)..., , BETHESDA, Md., Dec. 4 /PRNewswire-First...r the "Company") (OTC Bulletin Board: NWBO) announ...has allowed its patent application on a system for...re of the Company,s DCVax® therapeutic cancer... key to the very high concentration of dendritic c...
(Date:12/3/2009)..., , ALISO VIEJO, Calif. and STATE COLLEG...SoftGenetics today announced the signing of an agr... services using SoftGenetics, NextGENe software fo... Ambry. ,, (Logo: http://www.newscom.com/cg...sheidt PhD, Ambry,s CSO said, "Our team at Ambry h...
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Frost 26amp 3B Sullivan Identifies Focus on Quality Management and Adoption of a Full service Model as Keys to the Growth of the European CRO Market 5373 1Frost 26amp 3B Sullivan Identifies Focus on Quality Management and Adoption of a Full service Model as Keys to the Growth of the European CRO Market 5373 2Frost 26amp 3B Sullivan Identifies Focus on Quality Management and Adoption of a Full service Model as Keys to the Growth of the European CRO Market 5373 3Frost 26amp 3B Sullivan Identifies Focus on Quality Management and Adoption of a Full service Model as Keys to the Growth of the European CRO Market 5373 4Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR 28TM 29 Technology and Generate Novel Drug Leads Against a GPCR 14426 1Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR 28TM 29 Technology and Generate Novel Drug Leads Against a GPCR 14426 2Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR 28TM 29 Technology and Generate Novel Drug Leads Against a GPCR 14426 3Plastic Surgeon in Orlando Florida Helping New Moms Enhance their Figures after Pregnancy with a Mommy Makeover 59276 1Plastic Surgeon in Orlando Florida Helping New Moms Enhance their Figures after Pregnancy with a Mommy Makeover 59276 2Plastic Surgeon in Orlando Florida Helping New Moms Enhance their Figures after Pregnancy with a Mommy Makeover 59276 3[0] Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging[0] Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing[0] Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
...s of Disease Activity as Measured,by MRI and Relap...ech, Inc.,(NYSE: DNA) and Biogen Idec, Inc. (Nasda... II clinical study of Rituxan®,(rituximab) in ...is,(RRMS) were presented today at the American Aca...ituxan is a therapeutic antibody,that targets and ...
... reduced by 40 percent compared,to delayed treatme...lthCare,Pharmaceuticals announced today new data, ...on(R) (interferon beta-1b) treatment in,patients w... (MS),can significantly reduce the risk of permane...nded Disability Status Scale,(EDSS) by 40 percent(...
Other Medicine Technology:Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 3Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 4Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 6First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 2First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 3First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |